Additionally, there has been a recent investigation into this marker’s application in breast cancer and, based on Wfdc2 expression isolated in myoepithelial cells, we can predict that its efficacy in determining disease prognosis is more relevant for basal carcinomas than luminal (Chen et al., 2019). The gene discussed is WFDC2; the disease is breast carcinoma.